Pharmacology

Jeffrey N. Bryan, DVM, PhD, MS, DACVIM, discusses current methods and the need for advancement in how bone cancer is managed in dogs.

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum.

Sirolimus delayed-release tablets (felycin-CA1; PRN Pharmacal) have conditional approval from the FDA.

Tatiana Henriques Ferreira, DVM, PhD, MSc, DACVAA, and Marlis Rezende, DVM, PhD, MSc, DACVAA, discuss which types of cases are ideal for inhalant anesthesia vs total intravenous anesthesia.

Elanco Animal Health’s ilunocitinib tablet (Zenrelia) was approved by the FDA in 2024.

Marlis Rezende, DVM, PhD, MSc, DACVAA, discusses the common conditions she sees in practice that best utilize TIVA for pain management.

The latest canine otitis externa medication is the only FDA-approved, 1-dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens.

Royal Canin is highlighting the importance of a personalized health plan based on each pets' unique needs with these products and designated day for awareness

Lee Pope, DVM, discusses dosage tips to share with pet owners in a dvm360 interview.

Dechra’s Otiserene is a single-dose, long-acting product that utilizes marbofloxacin

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

The nutraceutical 4CYTE Epiitalis Forte Dog was previously only available abroad and is now distributed domestically by epiq Animal Health and Interpath Global.

OST-HER2 could be a frontline treatment for dogs and humans

The STAY study is investigating LOY-002, a therapy designed by Loyal to extend healthy lifespans in canines

The FDA has approved the new indication for Zoetis' Simparica Trio

Treating separation anxiety requires behavioral modification and medication, but which drug should you choose?

The entire hive can be treated for common bacterial diseases

Current levels of pain management administration by dairy producers and veterinarians in Europe and North America are low.

Felixvet has introduced a carprofen therapy with the same therapeutic benefits as Rimadyl

Communications expert Wendy S. Myers provides scripts for confident client conversations

In a dvm360 interview, Lee Pope, DVM, shares what veterinarians most-often request of their patients' medications.

Zoetis has launched its’ 0.5 mL dose for intranasal Vanguard B

Longevity drug developer Loyal and pain therapy manufacturer Elanco Animal Health are working with the organization to promote the need for aging canine care and enhance veterinary resources.

Jb Minter, DVM, MS, DACZM, discusses potential complications that can arise when amphibians are under anesthesia